I'm a PGY-4 in the Physician Scientist Training Program at MGH/McLean. I graduated from Dartmouth College with a neuroscience/chemistry degree in 2011, and graduated from the University of Michigan Medical School in 2018.
My research focuses on the use of population-level mathematical modeling to address issues in health economics and public health. After graduating from college, I spent three years working at MGH's Medical Practice Evaluation Center on projects assessing the cost-effectiveness of HIV treatment and prevention strategies in the US and abroad. Our work was instrumental in demonstrating that early treatment of HIV can be cost-effective, even in low-income settings. During medical school, I led similar cost-effectiveness analyses with collaborators in infectious diseases, ophthalmology, and psychiatry. In my most recent study, with Drs. Kara Zivin and Daniel Maixner, we evaluated the cost-effectiveness of electroconvulsive therapy for people with depression that has not responded to treatments such as medications and psychotherapy. We found that electroconvulsive therapy is a cost-effective and clinically beneficial option after failure of two prior treatments - we hope that this finding will help to guide clinical practice around this very challenging condition.
During my residency, I will be working with Dr. Djora Soeteman of Harvard's Center for Health Decision Sciences, as well as with clinical collaborators from both MGH and McLean. In our first study, we are working with Dr. Jenny Linnoila from the MGH Neurology department on evaluating the cost-effectiveness of screening or autoimmune encephalitis in patients with first-episode with psychosis.
